Annual CFI:
-$106.10M-$18.92M(-21.70%)Summary
- As of today, SPRY annual cash from investing is -$106.10 million, with the most recent change of -$18.92 million (-21.70%) on December 31, 2024.
- During the last 3 years, SPRY annual cash from investing has fallen by -$106.05 million (-192810.91%).
- SPRY annual cash from investing is now -192810.91% below its all-time high of -$55.00 thousand, reached on December 31, 2021.
Performance
SPRY Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFI:
-$44.98M-$93.55M(-192.61%)Summary
- As of today, SPRY quarterly cash from investing is -$44.98 million, with the most recent change of -$93.55 million (-192.61%) on September 30, 2025.
- Over the past year, SPRY quarterly cash from investing has dropped by -$61.80 million (-367.46%).
- SPRY quarterly cash from investing is now -192.61% below its all-time high of $48.57 million, reached on June 30, 2025.
Performance
SPRY Quarterly Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$69.11M-$61.80M(-845.75%)Summary
- As of today, SPRY TTM cash from investing is -$69.11 million, with the most recent change of -$61.80 million (-845.75%) on September 30, 2025.
- Over the past year, SPRY TTM cash from investing has dropped by -$90.80 million (-418.49%).
- SPRY TTM cash from investing is now -418.49% below its all-time high of $21.70 million, reached on September 30, 2024.
Performance
SPRY TTM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SPRY Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -21.7% | -367.5% | -418.5% |
| 3Y3 Years | -10000.0% | -10000.0% | -168.3% |
| 5Y5 Years | -10000.0% | - | - |
SPRY Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | >-9999.0% | at low | -192.6% | +59.7% | -418.5% | +39.0% |
| 5Y | 5-Year | >-9999.0% | at low | -192.6% | +59.7% | -418.5% | +39.0% |
| All-Time | All-Time | >-9999.0% | at low | -192.6% | +59.7% | -418.5% | +39.0% |
SPRY Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$44.98M(-192.6%) | -$69.11M(-845.8%) |
| Jun 2025 | - | $48.57M(+67.1%) | -$7.31M(+89.3%) |
| Mar 2025 | - | $29.06M(+128.6%) | -$68.52M(+35.4%) |
| Dec 2024 | -$106.10M(-21.7%) | -$101.76M(-705.1%) | -$106.10M(-589.0%) |
| Sep 2024 | - | $16.82M(+233.0%) | $21.70M(+152.0%) |
| Jun 2024 | - | -$12.65M(-48.5%) | -$41.76M(-363.4%) |
| Mar 2024 | - | -$8.51M(-132.7%) | $15.85M(+118.2%) |
| Dec 2023 | -$87.18M(>-9900.0%) | $26.04M(+155.8%) | -$87.18M(+23.0%) |
| Sep 2023 | - | -$46.64M(-203.7%) | -$113.22M(-70.0%) |
| Jun 2023 | - | $44.97M(+140.3%) | -$66.61M(+40.3%) |
| Mar 2023 | - | -$111.55M(>-9900.0%) | -$111.60M(-333.3%) |
| Dec 2022 | -$199.00K | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$30.00K(-36.4%) | -$25.76M(+60.8%) |
| Jun 2022 | - | -$22.00K(-4.8%) | -$65.79M(+1.0%) |
| Mar 2022 | - | -$21.00K(+99.9%) | -$66.46M(+0.0%) |
| Dec 2021 | -$55.00K(+94.0%) | - | - |
| Dec 2021 | - | -$25.68M(+35.9%) | -$66.48M(-63.0%) |
| Sep 2021 | - | -$40.06M(-5622.6%) | -$40.79M(-5450.1%) |
| Jun 2021 | - | -$700.00K(-1900.0%) | -$735.00K(-1737.5%) |
| Mar 2021 | - | -$35.00K(-600.0%) | -$40.00K(-5.3%) |
| Dec 2020 | -$917.00K(-855.2%) | - | - |
| Jun 2020 | - | -$5000.00(+84.8%) | -$38.00K(-15.2%) |
| Mar 2020 | - | -$33.00K | -$33.00K |
| Dec 2019 | -$96.00K(+78.6%) | - | - |
| Dec 2018 | -$449.00K | - | - |
FAQ
- What is ARS Pharmaceuticals, Inc. annual cash from investing?
- What is the all-time high annual cash from investing for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. annual cash from investing year-on-year change?
- What is ARS Pharmaceuticals, Inc. quarterly cash from investing?
- What is the all-time high quarterly cash from investing for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
- What is ARS Pharmaceuticals, Inc. TTM cash from investing?
- What is the all-time high TTM cash from investing for ARS Pharmaceuticals, Inc.?
- What is ARS Pharmaceuticals, Inc. TTM cash from investing year-on-year change?
What is ARS Pharmaceuticals, Inc. annual cash from investing?
The current annual cash from investing of SPRY is -$106.10M
What is the all-time high annual cash from investing for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high annual cash from investing is -$55.00K
What is ARS Pharmaceuticals, Inc. annual cash from investing year-on-year change?
Over the past year, SPRY annual cash from investing has changed by -$18.92M (-21.70%)
What is ARS Pharmaceuticals, Inc. quarterly cash from investing?
The current quarterly cash from investing of SPRY is -$44.98M
What is the all-time high quarterly cash from investing for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high quarterly cash from investing is $48.57M
What is ARS Pharmaceuticals, Inc. quarterly cash from investing year-on-year change?
Over the past year, SPRY quarterly cash from investing has changed by -$61.80M (-367.46%)
What is ARS Pharmaceuticals, Inc. TTM cash from investing?
The current TTM cash from investing of SPRY is -$69.11M
What is the all-time high TTM cash from investing for ARS Pharmaceuticals, Inc.?
ARS Pharmaceuticals, Inc. all-time high TTM cash from investing is $21.70M
What is ARS Pharmaceuticals, Inc. TTM cash from investing year-on-year change?
Over the past year, SPRY TTM cash from investing has changed by -$90.80M (-418.49%)